A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

Item

http://www.wikidata.org/entity/Q33751970

Q33751970

about

Emerging PSA-based tests to improve screening Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers Prediction models in cancer care.Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study.A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort Biomarkers in prostate cancer surveillance and screening: past, present, and future.Biomarkers for prostate cancer: present challenges and future opportunities.Novel biomarkers for the detection of prostate cancer.Active surveillance for low-risk prostate cancer: an update.Risk stratification in prostate cancer screening.The Kallikrein Panel for prostate cancer screening: its economic impact.The development of nomograms for stratification of men at risk of prostate cancer prior to prostate biopsy.Commercialized biomarkers: new horizons in prostate cancer diagnostics.Prostate-specific antigen-based prostate cancer screening: Past and future.Biomarkers in localized prostate cancer.Clinical Utility of Biomarkers in Localized Prostate Cancer.Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancer.Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above.The 4Kscore blood test accurately identifies men with aggressive prostate cancer prior to prostate biopsy with or without DRE information.Assays for prostate cancer : changing the screening paradigm?Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy.Recommandations de l’Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.Clinical performance of the 4Kscore Test to predict high-grade prostate cancer at biopsy: A meta-analysis of us and European clinical validation study results.Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men.The Use of Biomarkers in Prostate Cancer Screening and Treatment.Genomic biomarkers in prostate cancer

P2860

Q26828563-D05E2849-5028-4004-9DCA-29B41D12C036 Q28075610-20C8FE32-CC29-41BD-8986-50984334B12F Q35292878-F3F44907-C3D5-4C5E-AA3D-583FCB5B125B Q35854594-7ECB2A1D-09A4-4E94-B3A3-531B221BD824 Q36009824-D0C469C1-ACCD-4ACA-8335-6E5AAA9C4066 Q36275998-9D20D4A0-F18F-4E34-AC00-CCB3C91B212C Q37300931-8A004531-17BE-45A4-A3B0-954FBFA61300 Q37474443-3965088F-A0F4-4AE5-8247-67543D817A77 Q37708174-27293915-BB00-4F94-9141-D426F07F3026 Q37868926-B527F29C-2151-44E2-B5D4-D3D55C37B6E4 Q38068114-9D5441C0-E6C0-4480-AD32-47E8C0DE0C77 Q38156099-CAC011E7-EB50-482D-BC32-B9F7AA40A891 Q38165242-D3287CB4-D3B8-49E5-9AE3-3FBF8C51CF53 Q38364797-F1012109-0811-4206-851F-DB071B9CD524 Q38408501-1113A658-A064-456E-805A-4A216497594F Q38697114-2B28E7BC-D652-4788-A9F5-B53BA5F1D302 Q38792354-DDD28872-9B7C-40F8-8A30-4759FADA99F6 Q38854599-636EAE65-09FA-4606-9CBC-55FBD7E74D8D Q39331903-DED7351D-0D42-4AE5-9290-733163F431E7 Q40469023-419A08E4-ADCB-47B8-8534-D2ED2D2A8A79 Q46530327-DB1BF59C-CD81-45B2-B41E-E7BB58DAC2E4 Q46632925-920A17A2-E4A6-4B8B-8EF2-8299C216C260 Q47123251-508673A4-9EF7-4124-9837-DA4BD820E392 Q47568399-3ACF911F-2885-4139-A57F-8F7895E3AA6E Q52665993-055E37A8-4587-424C-A2A3-2D29C24F4FEC Q52689045-DF53A23B-8F6A-4444-8060-1F1399C74AAE Q57112354-8579FBBC-F0FE-4443-A569-C188379B6B9F

P2860

A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

Item

http://www.wikidata.org/entity/Q33751970

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu